Clinical Trial Update: Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder [NA]

View source ↗

Summary

This clinical trial update indicates that a study of transcutaneous auricular neurostimulation for relapse prevention in opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Snippet

Sponsor: Spark Biomedical, Inc. | Conditions: Opioid-use Disorder, Opioid Withdrawal | NA | Status: COMPLETED